After results for this sample were first published, the submitter contacted EcstasyData (see Description below) and asked to have it re-tested for an NBOMe or other high-potency psychedelic. The first pass analysis detected bk-MDMA with a small amount of 4-FA only.
The sample, which appeared to the naked eye to be fairly even and slightly damp or sticky, was initially misidentified because the lab did not notice that the material was not homogenous.
Under later examination with a magnifying glass, there were clearly different types and colors of crystals and powders mashed together that were not thoroughly mixed.
When the lab scooped a small amount of the material and homogenized it to complete the first pass analysis, they found two drugs. After preparing the sample for a second analysis, six drugs were found.
Material described as 'not a street drug', acquired from a lab outside the United States.
Submitter writes:
Your analysis says my sample is mostly bk-mdma with a small amount of 4-fa. I believe there is another chemical in the sample that was not detected. The trip reports for this specific substance [do] not match up at to methylone or 4-fa…
30-60mg nasal gave a MDA feeling with a psychedelic edge that felt a lot like lsd and lasted for 8-12 hours.
200mg nasal produced DMT like visuals, subject was thrown into dream states and was traveling through other worlds in her mind for 6 hours then was still high for 24 hours after the intense come-up.
200mg oral produces little effect.
It only works nasally and everyone has psychedelic responses and no one has been mixing any other substance while testing this chemical.
So maybe something was overlooked? Could there be trace amounts of something like 25b-nbome or any other nbome that would give us these psychedelic effects? methylone and 4fa do not have this effect at all.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
The sample, which appeared to the naked eye to be fairly even and slightly damp or sticky, was initially misidentified because the lab did not notice that the material was not homogenous.
Under later examination with a magnifying glass, there were clearly different types and colors of crystals and powders mashed together that were not thoroughly mixed.
When the lab scooped a small amount of the material and homogenized it to complete the first pass analysis, they found two drugs. After preparing the sample for a second analysis, six drugs were found.
Submitter writes: